Key result
Amiodarone reduced serum potassium from 4.0 to 3.3 mmol/L in a 70-year-old female cardiac patient (Naranjo score 10, definite ADR), normalizing to 3.8 mmol/L within 24 hours of withdrawal.
Why the study?
Amiodarone is a widely used class III antiarrhythmic agent for atrial and ventricular arrhythmias, but it can produce adverse systemic effects including clinically significant hypokalemia.
Case Report (n=1)
No
Answers are grounded in this paper and cite their sources.
This case report highlights that amiodarone, particularly when co-administered with insulin in elderly diabetic cardiac patients, can induce clinically significant hypokalemia that resolves rapidly upon drug discontinuation.
Amiodarone is a widely used class III antiarrhythmic agent for the treatment of atrial and ventricular arrhythmias but, one among many adverse systemic effects, it produces electrolytic disturbances, the common ones being the clinically significant hypokalemias. Methods: A 70-year-old female, with ischemic heart disease (EF 40%), type 2 diabetes mellitus, and hypertension, developed electrolyte imbalance during hospital stay. The medicines given to the patient and biochemical parameters were reviewed. The occurrence of an ADR was assessed by the Naranjo Scale. Results: The patient received ecosprin (aspirin + para-aminosalicylic acid), gemer (glimepiride +metformin), losar (losartan), storvas (atorvastatin), flavedon (trimetazidine), lantus (insulin glargine), clexane (enoxaparin), and axcer (ticagrelor). The fifth day saw the commencement of amiodarone 200 mg BD (cardarone) and syrup potkar 15 mL. Serum potassium was down from 4.0 mmol/L to 3.3 mmol/L on day 7. After withdrawal of the two drugs, serum potassium normalized to 3.8 mmol/L within 24 hours. This reaction was rated as definite (Naranjo score = 10) and moderate in severity. Discussion: Hypokalemia was thus induced by amiodarone with altered renal potassium regulation. Insulin administration could have also caused an intracellular shift of potassium. Early withdrawal of these offending agents brought about full recovery in the case presented. Conclusion: Emphasizing the case reports, this case claims the importance of regular monitoring of serum electrolytes in senile diabetic cardiac cases receiving amiodarone. Recognition at an early stage and timely pharmacovigilance intervention can avert the catastrophic complication.
No takes yet. Share an insight, caveat, or question.
Subba Dil Prasad (2026) conducted a case report in Amiodarone-induced hypokalemia in ischemic heart disease (n=1). Amiodarone was evaluated on Serum potassium level and Naranjo ADR causality score. Amiodarone reduced serum potassium from 4.0 to 3.3 mmol/L in a 70-year-old female cardiac patient (Naranjo score 10, definite ADR), normalizing to 3.8 mmol/L within 24 hours of withdrawal.
Synapse has enriched 10 related papers. Consider them for comparative context: